This company seems to have been delisted
Reason: Filed for bankruptcy
Last recorded trade on: October 20, 2023
Source: https://www.reuters.com/business/biotech-firm-amyris-files-bankruptcy-us-2023-08-10/
Reason: Filed for bankruptcy
Last recorded trade on: October 20, 2023
Source: https://www.reuters.com/business/biotech-firm-amyris-files-bankruptcy-us-2023-08-10/
Amyris
AMRS
HK$0.39
Share price
0.00%
Change (1 day)
-97.24%
Change (1 year)
EPS for Amyris (AMRS)
EPS in 2023 (TTM): -HK$14.35
According to Amyris's latest financial reports the company's current EPS (TTM) is -HK$14.22. In 2022 the company made an earnings per share (EPS) of -HK$12.74 a decrease over its 2021 EPS that were of -HK$7.77.
EPS history for Amyris from 2009 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -HK$14.35 | 12.58% |
| 2022 | -HK$12.74 | 64% |
| 2021 | -HK$7.77 | -48.19% |
| 2020 | -HK$15.00 | -30.82% |
| 2019 | -HK$21.68 | -22.28% |
| 2018 | -HK$27.90 | -2.45% |
| 2017 | -HK$28.60 | -29.9% |
| 2016 | -HK$40.80 | -82.76% |
| 2015 | -HK$236.61 | -6866.68% |
| 2014 | HK$3.50 | -100.97% |
| 2013 | -HK$361.33 | -17.33% |
| 2012 | -HK$437.10 | -6.02% |
| 2011 | -HK$465.07 | -79.68% |
| 2010 | -HK$2,289 | 49.59% |
| 2009 | -HK$1,530 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | -HK$66.21 | 365.57% | 🇺🇸 USA |
 | HK$220.37 | -1,649.73% | 🇺🇸 USA |
 | HK$7.38 | -151.91% | 🇺🇸 USA |
 | -HK$18.42 | 29.51% | 🇺🇸 USA |
 | -HK$3.34 | -76.50% | 🇺🇸 USA |
 | HK$75.30 | -629.51% | 🇺🇸 USA |